arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Cardio Diagnostics Holdings, Inc.

CDIO

$1.66 ▲ +0.01 (+0.61%) at close

22 Visible periods

24 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Cardio Diagnostics Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.9M

Dividend Yield —

Revenue Growth -28.3% ↘

Op. Margin —

ROIC -15.9% →

FCF / Share $-0.45 ↗

Trailing P/E —

Price / Book 0.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

22-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$5.36K

↓ -28.3% —

Net Income Profit after all expenses

$-1.50M

↑ +10.8% —

FCF / Share Free cash flow per share

$-0.45

↑ +17.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓

Financial Health ↑

Cash Quality →

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue Growth YoY (%)	-28.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-454%)	185.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2214%)	-21.2% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-365%)	-56.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-808%)	-5.0% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-163%)	-94.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1276%)	-15.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-288%)	-34.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-530%)	356.2% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+4353%)	—	458.9% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5637%)	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	47.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	35.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-185.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-1533.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-1516.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-385.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	62.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	84.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-81.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	100.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	5.9% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-143.8% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-57.1% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	10.8% Fair ↑ Fair Improving Year-over-year change in net income	-9.4% Weak ↑ Weak Improving Year-over-year change in net income	3.6% Caution ↑ Caution Improving Year-over-year change in net income	-21.4% Weak ↓ Weak Declining Year-over-year change in net income	-30.7% Weak ↓ Weak Declining Year-over-year change in net income	60.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-9.4% Weak ↑ Weak Improving Year-over-year change in net income	-36.8% Weak ↑ Weak Improving Year-over-year change in net income	-24.7% Weak ↑ Weak Improving Year-over-year change in net income	-303.2% Weak ↓ Weak Declining Year-over-year change in net income	41.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-256.0% Weak → Weak Stable Year-over-year change in net income	-256.0% Weak ↑ Weak Improving Year-over-year change in net income	-256.0% Weak ↑ Weak Improving Year-over-year change in net income	-283.7% Weak ↑ Weak Improving Year-over-year change in net income	-72961.7% Weak Weak Year-over-year change in net income	-72961.7% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	34.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-1302.5% Weak Weak Year-over-year change in free cash flow	—	—	—	65.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-292.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	45.9% Excellent Excellent Compound annual revenue growth over 3 years	—	55.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent → Excellent Stable Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
FCF / Net Income (x)	0.89x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	—	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.30x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.60x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	1.60x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	1.31x Good ↓ Good Declining Free cash flow relative to reported net income Optimal: > 1x	4.79x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.36x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	0.00x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Return on Invested Capital (%)	-15.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-15.8% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-16.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-12.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-33.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-108.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-41.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-63.1% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-87.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	-43.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	-58.0% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	-1.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-18.9% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-18.7% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-18.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-14.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-96.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-37.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-38.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-56.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-20.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-235%)	-20.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-234%)	-21.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-21.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-240%)	-17.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-215%)	-14.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	-15.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	-38.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-355%)	-41.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-379%)	-137.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1014%)	-47.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-413%)	-45.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-401%)	-35.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-337%)	-30.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-301%)	-55.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-469%)	-3.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-120%)	-3.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-120%)	-37.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-349%)	-58.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-487%)	-1.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-111%)	-1.6% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-111%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Interest Coverage (x)	-435.51x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-519.00x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-638.40x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-547.19x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-357.93x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-347.59x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-484.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-363.23x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-220.47x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-714.81x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-16.05x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2.53x Weak Weak Operating income divided by interest expense Optimal: > 5x	-2.43x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—
Net Debt (USD)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	—	—	—	$0.00	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	—	—	—
Basic EPS, GAAP (USD)	$-0.51	$-0.63	$-0.80	$-0.98	$-0.97	$-0.97	$-0.28	$-0.06	$-0.06	$-0.20	$0.00	$-0.16	$-0.39	$-0.11	$-1.09	$-0.17	$-0.16	$-0.07	—	—	—	—
Free Cash Flow per Share (USD)	$-0.45	$-0.55	—	$-0.89	—	$-0.83	—	—	—	$-0.06	—	—	—	$-0.17	—	$-0.21	$-0.07	$-0.04	—	—	—	—
Book Value per Share (USD)	$2.51	$3.01	$3.82	$4.61	$5.59	$6.54	$6.24	$0.12	$0.13	$0.14	$0.14	$0.17	$0.26	$0.36	$0.45	$1.45	$1.79	$0.18	$0.87	—	—	—
Tangible Book Value per Share (USD)	$2.51	$3.01	$3.82	$4.61	$5.59	$6.54	$6.24	$0.12	$0.13	$0.14	$0.14	$0.17	$0.26	$0.36	$0.45	$1.45	$1.79	$0.18	$0.87	—	—	—
Basic Weighted Avg Shares (shares)	2.96M	2.84M	—	1.76M	1.74M	1.69M	—	24.44M	22.61M	21.08M	—	11.90M	10.24M	9.55M	—	6.61M	5.43M	4.22M	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Working Capital (USD)	$5.80M	$7.25M	$5.32M	$6.53M	$8.33M	$9.99M	$8.16M	$2.32M	$1.76M	$1.90M	$1.92M	$1.57M	—	—	$3.94M	—	—	—	—	—	—	—
Total Equity (USD)	$7.43M	$8.90M	$6.97M	$8.15M	$9.72M	$11.38M	$9.56M	$3.69M	$3.07M	$3.04M	$2.96M	$2.29M	$2.91M	$3.42M	$4.30M	$9.57M	$9.70M	$778.05K	$1.07M	$24.28K	$24.60K	$60.37K

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗
Sales/Revenue/Turnover (USD)	$5.36K	$2.68K	$3.56K	$2.85K	$7.47K	$940.00	$4.51K	$6.58K	$7.87K	$15.93K	$5.31K	$10.03K	$1.73K	$0.00	$950.00	$0.00	$0.00	$0.00	—	—	—	—
Depreciation Expense (USD)	$44.28K	$44.24K	$44.22K	$40.40K	$37.78K	$37.66K	$37.44K	$36.76K	$35.99K	$3.59K	$2.41K	—	—	—	$0.00	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-1.50M	$-1.79M	$-1.47M	$-1.71M	$-1.68M	$-1.64M	$-1.52M	$-1.41M	$-1.29M	$-4.16M	$-1.39M	$-1.03M	$-1.03M	$-1.03M	$-2.38M	$-290.06K	$-290.06K	$-290.06K	$-619.73K	$-397.00	$-397.00	—
Operating Cash Flow (USD)	$-1.34M	$-1.56M	$-1.36M	$-1.39M	—	$-1.40M	$-1.39M	—	—	$-1.23M	$-1.69M	—	—	$-1.65M	$-3.12M	$-1.39M	$-394.77K	$-186.09K	$-585.12K	—	$0.00	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 6 years · 22 quarters

Cardio Diagnostics Holdings, Inc.

Analytical Summary

22-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CDIO with peers